Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas - Wikidata - awgldk - TriplyDB

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

http://www.wikidata.org/entity/Q34992260

about

Susceptibility pathways in Fanconi's anemia and breast cancer DNA methylation changes in epithelial ovarian cancer histotypes.BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas Predictive value of CHFR and MLH1 methylation in human gastric cancer.Epigenome-based personalized medicine in human cancer Fancf-deficient mice are prone to develop ovarian tumours The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.DNA methylation profiles in ovarian cancer: implication in diagnosis and therapy (Review)A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition.The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival.Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy Poly (ADP-ribose) polymerase inhibitors: recent advances and future development.Methylation of tumor suppressor genes in ovarian cancer.BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.Microbial L-methioninase: production, molecular characterization, and therapeutic applications.Role of epigenomics in ovarian and endometrial cancers.Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents.L-methionase: a therapeutic enzyme to treat malignancies.Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer.Identification of BRCA1-deficient ovarian cancers.Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

P2860

Q24628760-97A2B4E0-61CF-4BCB-9ACD-DF2504AB35C7 Q27690722-B6532B30-8F14-45F9-B591-C3828A341AE8 Q27851697-891A0F13-A8E0-4FFC-AF4F-11BE753F67F9 Q27852671-655A9F67-B81D-418D-A1A4-7F349EBA7943 Q27852998-40E6AE86-43F6-479B-9EED-F520EC420DB8 Q28083951-1765FA64-5E7D-4EBF-B21B-FAF6289EBEC1 Q28247935-ECC03A13-11B2-4877-B6A0-85541AACE2F7 Q28387891-E6A71226-86F0-4D1C-B98D-97B47622FFFC Q30419554-D0CE1CB3-D62B-44EE-BDF6-9C482266979D Q33553318-9DF1F674-C522-44B7-A795-6A96722F464F Q33799002-70F5BBB4-9C8E-41AB-ABC6-653AAAF9DCE3 Q34091420-13304BC8-29C9-401A-BD91-B088121C6809 Q34380980-6C841DF6-B5AB-441E-B940-1A50AAA1484B Q34455481-5FFD3D78-0A26-44CF-AE25-B5C08271DF27 Q34899498-5A4D8D6E-E020-4642-8AD5-E7015A5BD176 Q35034170-92D53FE7-AAA0-4C53-8E71-8FA0B0217EF3 Q35895214-BA8DEE13-10D3-47BF-9F93-84380452DC58 Q36386613-86BB7243-FE4A-469C-8A83-0F8D830DBE96 Q36747377-42CEDF12-82F3-438C-BFCF-51A6B3AF6753 Q37000936-FFE3A7AE-C92E-4B75-AA7E-893C87CD94C8 Q37469856-BA1F1D18-267B-44DA-8571-A426F227E341 Q37690196-A981FD18-99B5-4175-8E1D-CEB9EEFA44A6 Q37961734-10B42CC3-ADB6-41CB-98AE-D89117100431 Q39417419-6DD1AE79-A24E-49C8-A54F-5D9736943EC3 Q42877755-4AEA4864-4D1E-4861-A4F5-000EFB129A9E Q45814103-DCAE1609-8845-4C8D-921C-199BD369978D Q54384897-AE8F0FD7-A629-4D86-BF70-7A73D43F1397 Q57790341-325747A6-FA8D-4B14-9A04-70FC96A35078 Q59126243-618F6A8B-3D84-4FAD-ACF0-8E8C9029C18E

P2860

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

http://www.wikidata.org/entity/Q34992260

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Methylation and protein expres ...... rian and peritoneal carcinomas

@ast

Methylation and protein expres ...... rian and peritoneal carcinomas

@en

Methylation and protein expres ...... rian and peritoneal carcinomas

@nl

type

label

Methylation and protein expres ...... rian and peritoneal carcinomas

@ast

Methylation and protein expres ...... rian and peritoneal carcinomas

@en

Methylation and protein expres ...... rian and peritoneal carcinomas

@nl

prefLabel

Methylation and protein expres ...... rian and peritoneal carcinomas

@ast

Methylation and protein expres ...... rian and peritoneal carcinomas

@en

Methylation and protein expres ...... rian and peritoneal carcinomas

@nl

P1433

Q34992260-9255B500-E758-49C5-8403-6A9B23FE3E2C

P1476

Q34992260-BDE51665-4309-4C37-B0F4-F5673279ACE7

P2093

Q34992260-2329268B-EF74-407D-9077-789DF9B7A890

Q34992260-493C62B0-C363-4635-9124-2DDD324F083A

Q34992260-C7764B0D-7811-416F-9603-C756D0E0B8CC

Q34992260-DA053CC2-326B-4F8A-935B-4331B12DFDBF

Q34992260-F3FFB9BC-FDA0-4186-B41A-24AA7033F3E2

P2860

Q34992260-00922574-F87D-441D-A53F-69378DBB9FC8

Q34992260-0E7B03EF-3FCB-434D-91E0-86FFF563D50C

Q34992260-0F694AA3-96DD-4CB2-993A-8788A865C6B7

Q34992260-0FBC96EA-4CE2-4BCE-9ACF-7669AC14D629

Q34992260-14829C15-15E1-4C31-BC5F-F0842B7E8CA6

Q34992260-240B8FC2-0594-44B5-82C5-E3723AE3388F

Q34992260-24A370A1-DC16-4E13-9CEA-06DE547B2B35

Q34992260-28B7FB29-B138-474F-B760-B6D18D177396

Q34992260-31BB1469-509C-44D6-BB92-3C196B736589

Q34992260-328F4762-826D-4763-94F7-8BB9279A99EE

P2888

Q34992260-F3E32C42-E7DC-4192-BBE4-93348B1C2284

P304

Q34992260-75556201-CF62-4144-B6D7-483A04490BF8

P31

Q34992260-DA6F3205-FDFD-4B83-9574-865126429790

P356

Q34992260-124A9697-FEDC-464A-A345-5185FD5168D1

P478

Q34992260-A6654812-AADE-4A33-BC2D-63081F91D1C0

P50

Q34992260-3CAB7F28-D5D4-4FBB-8EEA-90A1636C88C4

Q34992260-F723A370-6A54-46F0-857F-2D95BE6640BC

P577

Q34992260-AAA5DC01-CEDC-4BB2-BB68-196FF9D876E3

P5875

Q34992260-6005CDA7-5C6B-4F41-B797-125E2A39A04E

P6179

Q34992260-0B207EB2-E4C9-4630-B2FA-A47AF393C061

P698

Q34992260-C1D30C05-95D7-4B4B-941F-D7865ECD7B41

P921

Q34992260-8D5448E9-03D3-4BAE-8316-2827131DEAD9

P932

Q34992260-F2CF47D2-96AF-48DA-9149-4DBB3C663741

P356

P1433

Molecular Cancer

P1476

Methylation and protein expres ...... rian and peritoneal carcinomas

@en

P2093

Barbara A Goff

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Swisher

http://www.w3.org/2001/XMLSchema#string

Piri Welcsh

http://www.w3.org/2001/XMLSchema#string

Rachel M Gonzalez

http://www.w3.org/2001/XMLSchema#string

Rochelle L Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

Resistance to therapy caused by intragenic deletion in BRCA2

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

Biallelic inactivation of BRCA2 in Fanconi anemia

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.

Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.

Localization of BRCA1 and a splice variant identifies the nuclear localization signal.

Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells.

P2888

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-8-48

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Toshiyasu Taniguchi

P577

2009-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26670900

http://www.w3.org/2001/XMLSchema#string

P6179

1002110614

http://www.w3.org/2001/XMLSchema#string

P698

19602291

http://www.w3.org/2001/XMLSchema#string

P921

P932

2719582

http://www.w3.org/2001/XMLSchema#string